Evidence map›Paper›PMID 40036261›Full record

ArticlePloS one2025

Inflammatory stimuli and hypoxia on atherosclerotic plaque thrombogenicity: Linking macrophage tissue factor and glycolysis.

Kazunari Maekawa, Eriko Nakamura, Yoichi Saito, Yunosuke Matsuura, Toshihiro Gi, Kensaku Nishihira, Nobuyuki Oguri, Sayaka Moriguchi-Goto, Yuichiro Sato, Kinta Hatakeyama and 5 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Kazunari MaekawaDepartment of Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki, Miyazaki, Japan.ORCID 0000-0002-5177-6242
Eriko NakamuraDepartment of Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki, Miyazaki, Japan.ORCID 0000-0002-3964-2831
Yoichi SaitoBioengineering Lab, Faculty of Advanced Science and Technology, Kumamoto University, Kumamoto, Kumamoto, Japan.
Yunosuke MatsuuraDivision of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Miyazaki, Japan.
Toshihiro GiDepartment of Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki, Miyazaki, Japan.ORCID 0000-0003-1422-9044
Kensaku NishihiraDepartment of Cardiology, Miyazaki Medical Association Hospital, Miyazaki, Miyazaki, Japan.ORCID 0000-0002-1718-3830
Nobuyuki OguriDepartment of Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki, Miyazaki, Japan.
Sayaka Moriguchi-GotoDepartment of Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki, Miyazaki, Japan.
Yuichiro SatoDepartment of Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki, Miyazaki, Japan.
Kinta HatakeyamaDepartment of Pathology, National Cerebral and Cardiovascular Center Hospital, Suita, Osaka, Japan.ORCID 0000-0001-7729-1836
Yoshisato ShibataDepartment of Cardiology, Miyazaki Medical Association Hospital, Miyazaki, Miyazaki, Japan.
Yoshihiro KomoharaDepartment of Cell Pathology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Kumamoto, Japan.
Koichi KaikitaDivision of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Miyazaki, Japan.
Yujiro AsadaDepartment of Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki, Miyazaki, Japan.
Atsushi YamashitaDepartment of Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki, Miyazaki, Japan.ORCID 0000-0001-5487-7594

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe thrombogenic potential of cells within atherosclerotic plaques is critical in the formation of a coronary thrombus. We hypothesized that a combination of inflammatory and hypoxic stimuli enhances tissue factor (TF) expression and glycolysis in cells in atherosclerotic plaques and contributes to coronary thrombus formation.

aimsTo identify TF- and hexokinase (HK)-II-expressing cells in coronary atherosclerotic plaques and thrombi and determine the effects of combined inflammatory and hypoxic stimuli and glycolysis on TF expression in peripheral blood mononuclear cell-derived macrophages.

methodsWe immunohistochemically assessed TF and HK-II expression in stable (n =  20) and unstable (n =  24) human coronary plaques and aspirated acute coronary thrombi (n =  15). The macrophages were stimulated with tumor necrosis factor-α, interferon-γ, or interleukin-10 under normoxic (21% O2) or hypoxic (1% O2) conditions, and TF expression was assessed.

resultsTF and HK-II expression were increased in unstable plaques compared with stable plaques. The number of CD68- and HK-II-immunopositive cells positively correlated with the number of TF-immunopositive cells. TF- and HK-II-expressing macrophages, which expressed M1- or M2-like markers, were involved in platelet-fibrin thrombus formation in ruptured plaques. The combination of inflammatory and hypoxic conditions additively augmented TF expression and procoagulant activity in the cultured macrophages. Inhibition of glycolysis with 2-deoxyglucose reduced the augmented TF expression and procoagulant activity.

conclusionCombined inflammatory and hypoxic conditions in atherosclerotic plaques may markedly enhance procoagulant activity in macrophages and contribute to coronary thrombus formation following plaque disruption. Macrophage TF expression may be associated with glycolysis.

Indexed as

GlycolysisHypoxiaInflammationPlaque, AtheroscleroticThromboplastinThrombosisAgedFemaleHexokinaseHumansInterferon-gammaInterleukin-10MacrophagesMaleMiddle AgedTumor Necrosis Factor-alphaHexokinaseHK2 protein, humanInterferon-gammaInterleukin-10ThromboplastinTumor Necrosis Factor-alpha

Identifiers

PMID40036261
PMCPMC11878908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.